News
Defensive response could help restrict tumour spreadCancer cells have been shown to mount a rapid, energy-intensive defence ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).
In biomedical research, spatial proteomics has become a surprisingly elegant weapon.
6d
Live Science on MSNExperimental HIV vaccines show promise in early safety testSeveral vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.
Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...
16h
ZME Science on MSNThis mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 YearsIn a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...
Researchers identified two ferroptosis-related genes that could serve as diagnostic biomarkers for idiopathic PAH.
With the launch of a U.S. trial, a treatment using the B-cell medicine BE-101 has been given to a hemophilia B patient for ...
In an exclusive Q&A, a Biogen exec discussed the developer's quest to 'rapidly' bring its experimental SMA therapy salanersen ...
The FDA has granted breakthrough therapy designation to DYNE-251 for the treatment of DMD in patients amenable to exon 51 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results